CYTOTECH ApS: Financial statements 2022
CVR: 19898504
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CYTOTECH ApS (CVR 19898504) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 272,977 and a net result of DKK 50,683 compared with DKK -14,508 the year before. That is an increase of 7.2% compared with the year before. Equity in the 2022 report amounted to DKK 237,565. The solvency ratio was 65.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 272,977
- Profit/Loss
- DKK 50,683
- Equity
- DKK 237,565
- Total Assets
- DKK 364,136
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 273 t. | 51 t. | 238 t. | 1 |
| 2021 | - | 255 t. | -15 t. | 187 t. | 1 |
| 2020 | - | 266 t. | -11 t. | 201 t. | 1 |
| 2019 | - | 378 t. | 149 t. | 212 t. | - |
| 2018 | - | 266 t. | 119 t. | 63 t. | - |
Official annual report
Keep an eye on CYTOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CYTOTECH ApS has published its annual report for 2021. Gross profit came to DKK 254,589, and the net result was DKK -14,508.
About CYTOTECH ApS
CYTOTECH ApS is a Danish company of the type Anpartsselskab based in Hellebæk, founded in 1997. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Patrick van Dijk Munch-Fals. The company is owned by Patrick van Dijk Munch-Fals. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 196,108 and a net result of DKK -70,656 compared with DKK -113,059 the year before. Equity in the 2025 report amounted to DKK -27,461.